# Safety of Treatment of Uterine Fibroids With Asoprisnil

> **NCT00156208** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 166 (actual)

## Conditions studied

- Fibroid Uterus
- Leiomyoma
- Menorrhagia
- Metrorrhagia
- Uterine Fibroids

## Interventions

- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil

## Key facts

- **NCT ID:** NCT00156208
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156208, "Safety of Treatment of Uterine Fibroids With Asoprisnil". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00156208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*